Outcome Of Pertrochanteric Fracture Following Intramedullary Fixation With PFN A

Abstract

Introduction:Pertrochanteric fractures, common among the elderly, present challenges in attaining a successful recovery to mobility. This research investigates the clinical outcomes and advantages of treating pertrochanteric fractures with intramedullary treatment utilizing the PFNA (Proximal Femoral Nail Antirotation) procedure.

Methods: Prospective researchhas been conducted with 24 patients who had PFNA treatment for pertrochanteric fractures between April 2022 and April 2023.Boyd and Griffin's classification was used to group the patients. Surgical techniques, side effects, and recovery after surgery were all thoroughly documented. The Harris Hip Score has been employed for clinical assessment.

Results:The patients' average age was 60.8 years, and women made up 75% of the population. Fractures were primarily a result of low-energy trauma, with 80% attributed to self-falls. PFNA surgery, with an average duration of 1 hour 29 min, demonstrated successful fracture union within 13 weeks. The six-month Harris Hip Score revealed outstanding outcomes in 20.8%, good in 66.6%, and fair in 12.5% of cases. Complications included abductor lurch, deep vein thrombosis (DVT), and superficial infections, all managed effectively.

Conclusion:The PFNA technique proves effective in achieving successful outcomes for pertrochanteric fractures in elderly patients. Shorter operating times, minimal blood loss, and favorable clinical results, as indicated by the Harris Hip Score, underscore PFNA's suitability as a preferred implantation approach. This study advocates for the continued exploration of PFNA's benefits in treating pertrochanteric fractures, emphasizing its potential for enhanced stability and mobility restoration in the elderly population.